Traws Pharma
TRAW
TRAW
8 hedge funds and large institutions have $4.36M invested in Traws Pharma in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $5.71M → $4.36M (-$1.35M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
8
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$115K | |
| 2 | +$105K | |
| 3 | +$55K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$28.7K |
| 5 |
Renaissance Technologies
New York
|
+$9.81K |
Top Sellers
| 1 | -$36K | |
| 2 | -$23.5K | |
| 3 | -$8K | |
| 4 |
HFM
Hartford Financial Management
Hartford,
Connecticut
|
-$3K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$1K |